市場調查報告書
商品編碼
935914

SNP基因型鑑定、分析的全球市場分析:各產品、各技術、各用途、各地區的未來預測

Global SNP Genotyping and Analysis Market Size study, by Product, by Technology, by Application and Regional Forecasts 2020-2026

出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 | 商品交期: 2-3個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球一鹼多型(SNP)基因型鑑定及分析的市場規模,在2019年估算為約150億美元,以及2020∼2026年預計將以21%以上的速度順利成長。SNP基因型鑑定的有效利用範圍,從個別化的遺傳基因檢驗到植物、動物用生物科技急速擴大著。再加上SNP基因型鑑定,也提供人類基因圖譜的分類和遺傳性疾病的轉移相關的想法。因此,為了預測疾病的相關性和對特定藥物療法的個人反應,在製藥及醫療領域獲得很大的價值。

本報告提供全球SNP基因型鑑定 (遺傳基因型判斷)、分析的市場相關分析,市場基本結構 (價值鏈等) 和主要的促進、阻礙因素,整體市場規模趨勢預測 (過去3年、今後8年份),各產品、各技術、各用途及各地區詳細趨勢,主要企業的簡介、市場佔有率等資訊彙整,為您概述為以下內容。

第1章 摘要整理

第2章 全球SNP基因型鑑定、分析市場:定義和範圍

第3章 全球SNP基因型鑑定、分析市場:市場動態

  • 對SNP基因型鑑定、分析市場的影響度分析
    • 推動市場要素
    • 市場課題
    • 市場機會

第4章 全球SNP基因型鑑定、分析市場:產業分析

  • 波特的五力分析
    • 供應商談判力
    • 買主談判力
    • 新加入企業的威脅
    • 替代品的威脅
    • 企業間競爭
    • 波特的五力分析:未來方法
  • PEST分析
    • 政治要素
    • 經濟要素
    • 社會要素
    • 技術性要素
  • 投資/引進模式
  • 分析師的建議與結論

第5章 全球 SNP基因型鑑定、分析市場:各產品

  • 市場概況
  • 市場成果,各產品:未來性分析
  • 市場估計值、預測值:各產品 (以金額為準)
  • 子區隔分析
    • 消耗品/試劑
    • 分析設備
    • 服務

第6章 全球 SNP基因型鑑定、分析市場:各技術

  • 市場概況
  • 市場成果,各技術:未來性分析
  • 市場估計值、預測值:各技術 (以金額為準)
  • 子區隔分析
    • Taqman allelic discrimination
    • 微陣列、SNP遺傳基因晶片
    • Sequenom Massarray
    • MALDI-TOF
    • Applied biosciences (AB) SNPlex
    • SNP焦磷酸測序
    • 其他

第7章 全球SNP基因型鑑定、分析市場:各用途

  • 市場概況
  • 市場成果,各用途:未來性分析
  • 市場估計值、預測值:各用途 (以金額為準)
  • 子區隔分析
    • 藥理基因學、醫藥品
    • 診斷分析
    • 育種、家畜
    • 農業、生物科技

第8章 全球SNP基因型鑑定、分析市場:各地區分析

  • SNP基因型鑑定、分析市場:各地區的市場概況
  • 北美市場
    • 美國
    • 加拿大
  • 歐洲市場
    • 英國
    • 德國
    • 其他
  • 亞太地區市場
    • 中國
    • 印度
    • 日本
    • 其他
  • 南美市場
    • 巴西
    • 墨西哥
  • 其他國家的市場 (RoW)

第9章 企業資料

  • 主要市場策略
  • 企業簡介
    • Sequenom, Inc.
    • Douglas Scientific LLC
    • PREMIER Biosoft
    • Luminex Corp.
    • Life Technologies Corp.
    • Fluidigm Corporation
    • Illumina, Inc.
    • Affymetrix, Inc.
    • Promega Corporation
    • Thermo Fischer Scientific Inc.

第10章 調查方法

目錄

Global SNP Genotyping and Analysis Market is valued approximately at USD 15 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 21% over the forecast period 2020-2026. Single Nucleotide Polymorphisms (SNP) genotyping is the practice of screening and examining of genetic variations of SNPs between members of a species. The use of SNP genotyping is rapidly growing from personalized genetic testing to plant and animal biotechnology. Since, it helps in identifying the correlations between the genotype and behavior revealed by all living organisms. Further, SNP genotyping also gives an idea about the human genome classification and transfer of hereditary diseases. Thus, it is gaining a huge value in the pharmaceutical and medical fields, as it predicts disease association and the individual's response for specific medication. Unlike the conventional time-consuming, labor-extensive and expensive detection technologies, SNP technology is considering as a highly efficient, relatively economical, and automated technology for genetic screening. Growing prevalence of incurable diseases such as cancer, diabetes and more, escalating demand for genetic analysis in animal and plant feedstock, and the high availability of private and public funding programs for genetics are the few factors responsible for high CAGR of the market over the forecast period. According to the International Diabetic Federation (IDF), the number of adults with diabetes was estimated around 415 million in 2015, and this number is projected to grow to almost 578 million by 2030, globally. Similarly, IDF also estimated that the number of diabetic patients in Europe is likely to rise from nearly 33 million in 2010 to 38 million in 2030. This, in turn, is expected to accelerate the demand for SNP Genotyping and Analysis, thus contributing to the growth of the global market. However, lack of standardization and privacy concerns in SNP process are the few factors expected to hamper the growth of the market over the forecast period of 2020-2026.

The regional analysis of global SNP Genotyping and Analysis market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the favorable government policies towards proper diagnosis and treatment of fatal diseases, along with the presence of extreme advanced technologies in the region. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2026, due to rise in incidences of targeted diseases and growing healthcare facilities in the countries like China and India.

Major market player included in this report are:

Sequenom, Inc.

Douglas Scientific LLC

PREMIER Biosoft

Luminex Corp.

Life Technologies Corp.

Fluidigm Corporation

Illumina, Inc.

Affymetrix, Inc.

Promega Corporation

Thermo Fischer Scientific Inc.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:

Consumables/Reagent

Instruments

Services

By Technology:

Taqman allelic discrimination

Microarrays & SNP genechips

Sequenom MassARRAY

MALDI-TOF

Applied biosciences (AB) SNPlex

SNP pyrosequencing

Others

By Application:

Pharmacogenomics & Pharmaceuticals

Diagnostic Research

Breeding & Animal livestock

Agricultural Biotechnology

By Region:

North America

U.S.

Canada

Europe

UK

Germany

Asia Pacific

China

India

Japan

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2016, 2017, 2018

Base year - 2019

Forecast period - 2020 to 2026

Target Audience of the Global SNP Genotyping and Analysis Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2018-2026 (USD Billion)
    • 1.2.1. SNP Genotyping and Analysis Market, by Region, 2018-2026 (USD Billion)
    • 1.2.2. SNP Genotyping and Analysis Market, by Product, 2018-2026 (USD Billion)
    • 1.2.3. SNP Genotyping and Analysis Market, by Technology, 2018-2026 (USD Billion)
    • 1.2.4. SNP Genotyping and Analysis Market, by Application, 2018-2026 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global SNP Genotyping and Analysis Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global SNP Genotyping and Analysis Market Dynamics

  • 3.1. SNP Genotyping and Analysis Market Impact Analysis (2018-2026)
    • 3.1.1. Market Drivers
    • 3.1.2. Market Challenges
    • 3.1.3. Market Opportunities

Chapter 4. Global SNP Genotyping and Analysis Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2016-2026)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion

Chapter 5. Global SNP Genotyping and Analysis Market, by Product

  • 5.1. Market Snapshot
  • 5.2. Global SNP Genotyping and Analysis Market by Product, Performance - Potential Analysis
  • 5.3. Global SNP Genotyping and Analysis Market Estimates & Forecasts by Product 2016-2026 (USD Billion)
  • 5.4. SNP Genotyping and Analysis Market, Sub Segment Analysis
    • 5.4.1. Consumables/Reagent
    • 5.4.2. Instruments
    • 5.4.3. Services

Chapter 6. Global SNP Genotyping and Analysis Market, by Technology

  • 6.1. Market Snapshot
  • 6.2. Global SNP Genotyping and Analysis Market by Technology, Performance - Potential Analysis
  • 6.3. Global SNP Genotyping and Analysis Market Estimates & Forecasts by Technology 2016-2026 (USD Billion)
  • 6.4. SNP Genotyping and Analysis Market, Sub Segment Analysis
    • 6.4.1. Taqman allelic discrimination
    • 6.4.2. Microarrays & SNP genechips
    • 6.4.3. Sequenom Massarray
    • 6.4.4. MALDI-TOF
    • 6.4.5. Applied biosciences (AB) SNPlex
    • 6.4.6. SNP pyrosequencing
    • 6.4.7. Others

Chapter 7. Global SNP Genotyping and Analysis Market, by Application

  • 7.1. Market Snapshot
  • 7.2. Global SNP Genotyping and Analysis Market by Application, Performance - Potential Analysis
  • 7.3. Global SNP Genotyping and Analysis Market Estimates & Forecasts by Application 2016-2026 (USD Billion)
  • 7.4. SNP Genotyping and Analysis Market, Sub Segment Analysis
    • 7.4.1. Pharmacogenomics & Pharmaceuticals
    • 7.4.2. Diagnostic Research
    • 7.4.3. Breeding & Animal livestock
    • 7.4.4. Agricultural Biotechnology

Chapter 8. Global SNP Genotyping and Analysis Market, Regional Analysis

  • 8.1. SNP Genotyping and Analysis Market, Regional Market Snapshot
  • 8.2. North America SNP Genotyping and Analysis Market
    • 8.2.1. U.S. SNP Genotyping and Analysis Market
      • 8.2.1.1. Product breakdown estimates & forecasts, 2016-2026
      • 8.2.1.2. Technology breakdown estimates & forecasts, 2016-2026
      • 8.2.1.3. Application breakdown estimates & forecasts, 2016-2026
    • 8.2.2. Canada SNP Genotyping and Analysis Market
  • 8.3. Europe SNP Genotyping and Analysis Market Snapshot
    • 8.3.1. U.K. SNP Genotyping and Analysis Market
    • 8.3.2. Germany SNP Genotyping and Analysis Market
    • 8.3.3. Rest of Europe SNP Genotyping and Analysis Market
  • 8.4. Asia-Pacific SNP Genotyping and Analysis Market Snapshot
    • 8.4.1. China SNP Genotyping and Analysis Market
    • 8.4.2. India SNP Genotyping and Analysis Market
    • 8.4.3. Japan SNP Genotyping and Analysis Market
    • 8.4.4. Rest of Asia Pacific SNP Genotyping and Analysis Market
  • 8.5. Latin America SNP Genotyping and Analysis Market Snapshot
    • 8.5.1. Brazil SNP Genotyping and Analysis Market
    • 8.5.2. Mexico SNP Genotyping and Analysis Market
  • 8.6. Rest of The World SNP Genotyping and Analysis Market

Chapter 9. Competitive Intelligence

  • 9.1. Top Market Strategies
  • 9.2. Company Profiles
    • 9.2.1. Sequenom, Inc.
      • 9.2.1.1. Key Information
      • 9.2.1.2. Overview
      • 9.2.1.3. Financial (Subject to Data Availability)
      • 9.2.1.4. Product Summary
      • 9.2.1.5. Recent Developments
    • 9.2.2. Douglas Scientific LLC
    • 9.2.3. PREMIER Biosoft
    • 9.2.4. Luminex Corp.
    • 9.2.5. Life Technologies Corp.
    • 9.2.6. Fluidigm Corporation
    • 9.2.7. Illumina, Inc.
    • 9.2.8. Affymetrix, Inc.
    • 9.2.9. Promega Corporation
    • 9.2.10. Thermo Fischer Scientific Inc.

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption

List of Tables

List of Tables

  • TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF GLOBAL SNP GENOTYPING AND ANALYSIS MARKET
  • TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF GLOBAL SNP GENOTYPING AND ANALYSIS MARKET
  • TABLE 3. GLOBAL SNP GENOTYPING AND ANALYSIS MARKET, REPORT SCOPE
  • TABLE 4. YEARS CONSIDERED FOR THE STUDY
  • TABLE 5. EXCHANGE RATES CONSIDERED
  • TABLE 6. GLOBAL SNP GENOTYPING AND ANALYSIS MARKET ESTIMATES & FORECASTS BY REGION 2016-2026 (USD BILLION)
  • TABLE 7. GLOBAL SNP GENOTYPING AND ANALYSIS MARKET ESTIMATES & FORECASTS BY PRODUCT 2016-2026 (USD BILLION)
  • TABLE 8. GLOBAL SNP GENOTYPING AND ANALYSIS MARKET ESTIMATES & FORECASTS BY TECHNOLOGY 2016-2026 (USD BILLION)
  • TABLE 9. GLOBAL SNP GENOTYPING AND ANALYSIS MARKET ESTIMATES & FORECASTS BY APPLICATION 2016-2026 (USD BILLION)
  • TABLE 10. GLOBAL SNP GENOTYPING AND ANALYSIS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 11. GLOBAL SNP GENOTYPING AND ANALYSIS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 12. GLOBAL SNP GENOTYPING AND ANALYSIS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 13. GLOBAL SNP GENOTYPING AND ANALYSIS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 14. GLOBAL SNP GENOTYPING AND ANALYSIS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 15. GLOBAL SNP GENOTYPING AND ANALYSIS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 16. GLOBAL SNP GENOTYPING AND ANALYSIS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 17. GLOBAL SNP GENOTYPING AND ANALYSIS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 18. GLOBAL SNP GENOTYPING AND ANALYSIS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 19. GLOBAL SNP GENOTYPING AND ANALYSIS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 20. U.S. SNP GENOTYPING AND ANALYSIS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 21. U.S. SNP GENOTYPING AND ANALYSIS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 22. U.S. SNP GENOTYPING AND ANALYSIS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 23. CANADA SNP GENOTYPING AND ANALYSIS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 24. CANADA SNP GENOTYPING AND ANALYSIS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 25. CANADA SNP GENOTYPING AND ANALYSIS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 26. UK SNP GENOTYPING AND ANALYSIS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 27. UK SNP GENOTYPING AND ANALYSIS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 28. UK SNP GENOTYPING AND ANALYSIS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 29. GERMANY SNP GENOTYPING AND ANALYSIS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 30. GERMANY SNP GENOTYPING AND ANALYSIS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 31. GERMANY SNP GENOTYPING AND ANALYSIS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 32. ROE SNP GENOTYPING AND ANALYSIS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 33. ROE SNP GENOTYPING AND ANALYSIS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 34. ROE SNP GENOTYPING AND ANALYSIS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 35. CHINA SNP GENOTYPING AND ANALYSIS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 36. CHINA SNP GENOTYPING AND ANALYSIS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 37. CHINA SNP GENOTYPING AND ANALYSIS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 38. INDIA SNP GENOTYPING AND ANALYSIS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 39. INDIA SNP GENOTYPING AND ANALYSIS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 40. INDIA SNP GENOTYPING AND ANALYSIS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 41. JAPAN SNP GENOTYPING AND ANALYSIS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 42. JAPAN SNP GENOTYPING AND ANALYSIS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 43. JAPAN SNP GENOTYPING AND ANALYSIS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 44. ROAPAC SNP GENOTYPING AND ANALYSIS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 45. ROAPAC SNP GENOTYPING AND ANALYSIS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 46. ROAPAC SNP GENOTYPING AND ANALYSIS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 47. BRAZIL SNP GENOTYPING AND ANALYSIS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 48. BRAZIL SNP GENOTYPING AND ANALYSIS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 49. BRAZIL SNP GENOTYPING AND ANALYSIS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 50. MEXICO SNP GENOTYPING AND ANALYSIS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 51. MEXICO SNP GENOTYPING AND ANALYSIS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 52. MEXICO SNP GENOTYPING AND ANALYSIS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 53. ROLA SNP GENOTYPING AND ANALYSIS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 54. ROLA SNP GENOTYPING AND ANALYSIS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 55. ROLA SNP GENOTYPING AND ANALYSIS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 56. ROW SNP GENOTYPING AND ANALYSIS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 57. ROW SNP GENOTYPING AND ANALYSIS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 58. ROW SNP GENOTYPING AND ANALYSIS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

List of Figures

List of Figures

  • FIG 1. GLOBAL SNP GENOTYPING AND ANALYSIS MARKET, RESEARCH METHODOLOGY
  • FIG 2. GLOBAL SNP GENOTYPING AND ANALYSIS MARKET, MARKET ESTIMATION TECHNIQUES
  • FIG 3. GLOBAL MARKET SIZE ESTIMATES & FORECAST METHODS
  • FIG 4. GLOBAL SNP GENOTYPING AND ANALYSIS MARKET, KEY TRENDS 2019
  • FIG 5. GLOBAL SNP GENOTYPING AND ANALYSIS MARKET, GROWTH PROSPECTS 2020-2026
  • FIG 6. GLOBAL SNP GENOTYPING AND ANALYSIS MARKET, PORTERS 5 FORCE MODEL
  • FIG 7. GLOBAL SNP GENOTYPING AND ANALYSIS MARKET, PEST ANALYSIS
  • FIG 8. GLOBAL SNP GENOTYPING AND ANALYSIS MARKET, VALUE CHAIN ANALYSIS
  • FIG 9. GLOBAL SNP GENOTYPING AND ANALYSIS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 10. GLOBAL SNP GENOTYPING AND ANALYSIS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 11. GLOBAL SNP GENOTYPING AND ANALYSIS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 12. GLOBAL SNP GENOTYPING AND ANALYSIS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 13. GLOBAL SNP GENOTYPING AND ANALYSIS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 14. GLOBAL SNP GENOTYPING AND ANALYSIS MARKET, REGIONAL SNAPSHOT 2016 & 2026
  • FIG 15. NORTH AMERICA SNP GENOTYPING AND ANALYSIS MARKET 2016 & 2026 (USD BILLION)
  • FIG 16. EUROPE SNP GENOTYPING AND ANALYSIS MARKET 2016 & 2026 (USD BILLION)
  • FIG 17. ASIA PACIFIC SNP GENOTYPING AND ANALYSIS MARKET 2016 & 2026 (USD BILLION)
  • FIG 18. LATIN AMERICA SNP GENOTYPING AND ANALYSIS MARKET 2016 & 2026 (USD BILLION)
  • FIG 19. GLOBAL SNP GENOTYPING AND ANALYSIS MARKET, COMPANY MARKET SHARE ANALYSIS (2019)